Hormone therapy has become an increasingly important part of the conversation surrounding menopause and women’s health. Yet many women remain confused by conflicting information about estrogen, progesterone, the risks and benefits of HRT, when treatment should begin, and which forms of hormone therapy may be appropriate.
The articles and videos in this HRT Resource Center are designed to help answer those questions.
Every woman’s experience with menopause is different, and Hormone Replacement Therapy is not a one-size-fits-all treatment.
This resource center brings together articles and videos from Steven R. Goldstein, MD, to help women better understand HRT and make more informed decisions about their health. He has been using HRT for more than 35 years to help women cope with the symptoms of menopause and other conditions, and is the author of The Estrogen Alternative, one of the early books written to help women better understand hormone therapy and their treatment options.
Start exploring the HRT Resource Center below to learn more about your symptoms, your treatment options, and the questions you should be asking about your health.
For many women, the journey through perimenopause and menopause can feel like navigating uncharted waters. The hormonal shifts bring a host of challenging symptoms, from hot flashes and night sweats to mood swings and vaginal dryness. In the search for...
Read More
Dr Steven R. Goldstein, a Menopause Specialist NYC, is a past President of the International Menopause Society, The Menopause Society, and is a Certified Menopause Practitioner. Dr Goldstein has seen a noticeable rise in interest for the use of testosterone...
Read More
Dr Steven R. Goldstein, a Perimenopause Specialist NYC comments on the increasing use of HRT for Perimenopause. Is HRT good for Perimenopause? Simply giving traditional hormone replacement therapy such as estrogen patches and progesterone pills, or progesterone IUDs (as many...
Read More
Many of you may have seen the article in the New York Times and other news media outlets relative to the breast cancer drug tamoxifen. As many of you know, I was involved in the STAR trial which compared tamoxifen and raloxifene...
Read More
